These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 150078)

  • 1. Difficulties in predicting bone-marrow graft rejection in patients with aplastic anemia.
    Elfenbein GJ; Anderson PN; Klein DL; Schacter BZ; Santos GW
    Transplant Proc; 1978 Jun; 10(2):441-5. PubMed ID: 150078
    [No Abstract]   [Full Text] [Related]  

  • 2. Direct and antibody-dependent cell-mediated cytotoxicity against HLA identical sibling lymphocytes. Correlation with marrow graft rejections.
    Warren RP; Storb R; Weiden PL; Mickelson EM; Thomas ED
    Transplantation; 1976 Dec; 22(6):631-5. PubMed ID: 137561
    [No Abstract]   [Full Text] [Related]  

  • 3. Possible role of lymphocyte cytotoxicity in bone-marrow grafting.
    Oldham RK; Simmler MC
    Transplant Proc; 1974 Dec; 6(4):417-9. PubMed ID: 4280166
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunological mechanisms in aplastic anemia. III. Arguments against the role of primary immunologic disorders in aplastic anemia: effect of transfusion of blood components on the course of aplastic anemia].
    Rupniewska ZM; Dmoszyńska-Giannopoulos A
    Przegl Lek; 1982; 39(12):821-3. PubMed ID: 6762620
    [No Abstract]   [Full Text] [Related]  

  • 5. The detection of non-HLA antibodies and their possible role in bone marrow graft rejection.
    Claas FH; van Rood JJ; Warren RP; Weiden PL; Su PJ; Storb R
    Transplant Proc; 1979 Mar; 11(1):423-6. PubMed ID: 377669
    [No Abstract]   [Full Text] [Related]  

  • 6. Aplastic anemia treated by marrow transplantation.
    Buckner CD; Clift RA; Fefer A; Funk DD; Glucksberg H; Ramberg RE; Storb R; Thomas ED
    Transplant Proc; 1973 Mar; 5(1):913-6. PubMed ID: 4144472
    [No Abstract]   [Full Text] [Related]  

  • 7. Relevance of major human histocompatibility determinants in clinical bone marrow transplantation.
    Hansen JA; O'Reilly RJ; Good RA; Dupont B
    Transplant Proc; 1976 Dec; 8(4):581-9. PubMed ID: 63170
    [No Abstract]   [Full Text] [Related]  

  • 8. Prolonged remission of severe aplastic anemia after ALG pretreatment and HL-A-semi-incompatible bone-marrow cell transfusion.
    Jeannet M; Rubinstein A; Pelet B; Kummer H
    Transplant Proc; 1974 Dec; 6(4):359-63. PubMed ID: 4280163
    [No Abstract]   [Full Text] [Related]  

  • 9. Prognostic value of antibody-dependent assays for presensitization in bone marrow transplant recipients.
    Parkman R; Rappeport J; Camitta B; Levey R; Rosen FS
    Transplant Proc; 1978 Mar; 10(1):71-3. PubMed ID: 345568
    [No Abstract]   [Full Text] [Related]  

  • 10. Analysis of cytotoxic effector cell function in patients with leukemia or aplastic anemia before and after marrow transplantation.
    Livnat S; Seigneuret M; Storb R; Prentice RL
    J Immunol; 1980 Jan; 124(1):481-90. PubMed ID: 6765970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The early diagnosis of renal allograft rejection in man.
    Carpenter CB
    Adv Nephrol Necker Hosp; 1975; 5():229-56. PubMed ID: 127521
    [No Abstract]   [Full Text] [Related]  

  • 12. Allogeneic bone marrow transplantation in aplastic anemia--report of 25 cases.
    Gluckman E; Devergie A; Marty M; Bussel A; Rottemboúrg J; Dausset J; Bernard J
    Transplant Proc; 1978 Mar; 10(1):141-5. PubMed ID: 345552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hematopoietic stem-cell transplantation in aplastic anemia].
    Hernández-Rivera EG
    Rev Invest Clin; 2005; 57(2):298-304. PubMed ID: 16524071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow transplantation for aplastic anemia or acute leukemia.
    Thomas ED
    Scand J Urol Nephrol Suppl; 1977; (42):6-11. PubMed ID: 356224
    [No Abstract]   [Full Text] [Related]  

  • 15. Preceding transfusions and marrow graft rejection in dogs and man.
    Weiden PL; Storb R; Thomas ED; Graham TC; Lerner KG; Buckner CD; Fefer A; Neiman PE; Clift RA
    Transplant Proc; 1976 Dec; 8(4):551-4. PubMed ID: 793113
    [No Abstract]   [Full Text] [Related]  

  • 16. Case problems in bone marrow transplantation. I. Graft failure in aplastic anemia: its biology and treatment.
    Champlin RE; Feig SA; Gale RP
    Exp Hematol; 1984 Oct; 12(9):728-33. PubMed ID: 6386510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of factors related to bone marrow graft rejection in aplastic anemia: usefulness of measures of broad alloimmunity as predictors.
    Elfenbein G; Kallman C; Braine H; Bias W; Tutschka P; Karp J; Burke P; Wharam M; Saral R; Kaizer H; Mellits E; Santos G
    Transplant Proc; 1981 Sep; 13(3):1539-43. PubMed ID: 7029810
    [No Abstract]   [Full Text] [Related]  

  • 18. Humoral and cellular cross-match tests before bone-marrow transplantation [proceedings].
    Jeannet M; Legendre C; Speck B
    Pathol Biol (Paris); 1978 Jan; 26(1):17. PubMed ID: 358070
    [No Abstract]   [Full Text] [Related]  

  • 19. [Allogenic hematopoietic stem cell transplantation in acquired aplastic anemia: first experience of the National Center for Bone Marrow Grafting].
    Abdelkefi A; Ladeb S; Ben Othman T; Torjman L; Jeddi R; Ben Abdeladhim A
    Tunis Med; 2001 Oct; 79(10):498-502. PubMed ID: 11910688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunologic mechanisms in aplastic anemia.
    Finlay JL; Ershler WB; Shahidi NT
    Am J Pediatr Hematol Oncol; 1980; 2(3):223-32. PubMed ID: 7001943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.